Omeros (OMER) Other Gross PP&E Adjustments (2011 - 2026)
Omeros recorded quarterly Other Gross PP&E Adjustments of $2.0 million in Q1 2026, up 196.09% quarter-over-quarter from $690000.0 in Q4 2025, and up 183.73% year-over-year from $720052.0 in Q1 2025.
Omeros' Other Gross PP&E Adjustments history runs 16 years deep, the most recent figure standing at $2.0 million for Q1 2026.
- In Q1 2026, Other Gross PP&E Adjustments rose 183.73% year-over-year to $2.0 million; the TTM figure through Mar 2026 stood at $2.0 million (up 183.73% YoY), while the FY2025 annual figure was $690000.0, up 118.1% from the prior year.
- Other Gross PP&E Adjustments came in at $2.0 million for Q1 2026 at Omeros, up from $690000.0 in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $2.0 million in Q1 2026 to a low of -$18.7 million in Q1 2022.
- A 5-year average of -$7.7 million and a median of -$7.8 million in 2024 frame the typical range for Other Gross PP&E Adjustments.
- Across the five-year window, Other Gross PP&E Adjustments advanced 5.49% in 2022 and jumped 183.73% in 2026, its largest moves.
- Omeros' Other Gross PP&E Adjustments stood at -$15.1 million in 2022, then soared by 34.12% to -$10.0 million in 2023, then jumped by 61.79% to -$3.8 million in 2024, then jumped by 118.1% to $690000.0 in 2025, then soared by 196.09% to $2.0 million in 2026.
- According to Business Quant data, Other Gross PP&E Adjustments over the past three periods registered $2.0 million, $690000.0, and $1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | 2.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.04 Mn |
| Mar 31, 2026 | 2.04 Mn |
| Dec 31, 2025 | 690,000.00 |
| Dec 31, 2025 | 690,000.00 |
| Sep 30, 2025 | 1.08 Mn |
| Sep 30, 2025 | 1.08 Mn |
| Jun 30, 2025 | -694,000.00 |
| Jun 30, 2025 | -694,000.00 |
| Mar 31, 2025 | -2.44 Mn |
| Mar 31, 2025 | -2.44 Mn |
| Dec 31, 2024 | -3.81 Mn |
| Dec 31, 2024 | -3.81 Mn |
| Sep 30, 2024 | -4.52 Mn |
| Sep 30, 2024 | -4.52 Mn |
| Jun 30, 2024 | -7.33 Mn |
| Jun 30, 2024 | -7.33 Mn |
| Mar 31, 2024 | -7.83 Mn |
| Mar 31, 2024 | -7.83 Mn |
| Dec 31, 2023 | -9.98 Mn |
| Dec 31, 2023 | -9.98 Mn |
| Sep 30, 2023 | -10.71 Mn |
| Sep 30, 2023 | -10.71 Mn |
| Jun 30, 2023 | -11.57 Mn |
| Jun 30, 2023 | -11.57 Mn |
| Mar 31, 2023 | -13.87 Mn |
| Mar 31, 2023 | -13.87 Mn |
| Dec 31, 2022 | -15.15 Mn |
| Dec 31, 2022 | -15.15 Mn |
| Sep 30, 2022 | -13.20 Mn |
| Sep 30, 2022 | -13.20 Mn |
| Jun 30, 2022 | -14.95 Mn |
| Jun 30, 2022 | -14.95 Mn |
| Mar 31, 2022 | -18.70 Mn |
| Mar 31, 2022 | -18.70 Mn |
| Dec 31, 2021 | -28.84 Mn |
| Dec 31, 2021 | -28.84 Mn |
| Sep 30, 2021 | -22.55 Mn |
| Sep 30, 2021 | -22.55 Mn |
| Jun 30, 2021 | -24.30 Mn |
| Jun 30, 2021 | -24.30 Mn |
| Mar 31, 2021 | -19.79 Mn |
| Mar 31, 2021 | -19.79 Mn |
| Dec 31, 2020 | -25.91 Mn |
| Dec 31, 2020 | -25.91 Mn |
| Sep 30, 2020 | -21.39 Mn |
| Sep 30, 2020 | -21.39 Mn |
| Jun 30, 2020 | -19.97 Mn |
| Jun 30, 2020 | -19.97 Mn |
| Mar 31, 2020 | -22.21 Mn |
| Mar 31, 2020 | -22.21 Mn |
| Dec 31, 2019 | -27.18 Mn |
| Dec 31, 2019 | -27.18 Mn |
| Sep 30, 2019 | -15.17 Mn |
| Sep 30, 2019 | -15.17 Mn |
| Jun 30, 2019 | -10.67 Mn |
| Jun 30, 2019 | -10.67 Mn |
| Mar 31, 2019 | -11.76 Mn |
| Mar 31, 2019 | -11.76 Mn |
| Dec 31, 2018 | -879,000.00 |
| Dec 31, 2018 | -879,000.00 |
| Dec 31, 2017 | -2.43 Mn |
| Dec 31, 2017 | -2.43 Mn |
| Dec 31, 2016 | -7.19 Mn |
| Dec 31, 2016 | -7.19 Mn |
| Dec 31, 2015 | -4.75 Mn |
| Dec 31, 2015 | -4.75 Mn |
| Dec 31, 2014 | -2.73 Mn |
| Dec 31, 2014 | -2.73 Mn |
| Dec 31, 2013 | -738,000.00 |
| Dec 31, 2013 | -738,000.00 |
| Sep 30, 2013 | -467,000.00 |
| Sep 30, 2013 | -467,000.00 |
| Jun 30, 2013 | -373,000.00 |
| Jun 30, 2013 | -373,000.00 |
| Dec 31, 2012 | 412,000.00 |
| Dec 31, 2012 | 412,000.00 |
| Dec 31, 2011 | 1.71 Mn |
| Dec 31, 2011 | 1.71 Mn |